Skip to content

MES

  • MES
    • Ulf Kahlert
    • Team
    • Publications
    • Lab infrastructure
  • Research
    • Patient-material biobank
    • Tumor biology
    • Surgical trauma
    • Blood tests
    • Nanomedicine
    • Reproducibility
  • News
  • Cooperations
  • Contact

All news are regularly updated on our institutional homepage

  • Post author:Ulf Kahlert
  • Post published:25. June 2024
  • Post category:Allgemein

The news feature on our institution homepage gives up to date updates on new developments at MES.

Continue ReadingAll news are regularly updated on our institutional homepage
Read more about the article Science meets business

Science meets business

  • Post author:Ulf Kahlert
  • Post published:1. February 2024
  • Post category:MES

Thanks Alex for igniting the business envelop. Exited for this journey to come...

Continue ReadingScience meets business
Read more about the article Student evaluation

Student evaluation

  • Post author:Ulf Kahlert
  • Post published:23. January 2024
  • Post category:News

The Erasmus Programm ("EuRopean Community Action Scheme for the Mobility of University Students") is a European Union (EU) student exchange program established in 1987. Erasmus+,…

Continue ReadingStudent evaluation
Read more about the article Nomination in scientific society

Nomination in scientific society

  • Post author:Ulf Kahlert
  • Post published:19. January 2024
  • Post category:News

Ulf Kahlert was nominated in another scientific Society, this time as a full member into Sigma Xi, The Scientific Research Honor Society (Well Cornell, USA).…

Continue ReadingNomination in scientific society
Read more about the article MES New Years Brunch 2024

MES New Years Brunch 2024

  • Post author:Ulf Kahlert
  • Post published:13. January 2024
  • Post category:News

To a good start in the New Year and prosper 2024 for all.

Continue ReadingMES New Years Brunch 2024
Read more about the article James Lu-  foreign member of Academia Europaea visits our lab

James Lu- foreign member of Academia Europaea visits our lab

  • Post author:Ulf Kahlert
  • Post published:13. January 2024
  • Post category:MES

It was a great honor to host James Lu in our lab. New cooperation projects have been initiated and coordinated programs for strategic staff exchanges…

Continue ReadingJames Lu- foreign member of Academia Europaea visits our lab
Read more about the article 2023 – 14 publication, 92 total Impact factor points

2023 – 14 publication, 92 total Impact factor points

  • Post author:Ulf Kahlert
  • Post published:13. January 2024
  • Post category:News

In the year 2023 our lab has published 14 papers with a total Impact of 92 points. Academic exploitation of our research is one of…

Continue Reading2023 – 14 publication, 92 total Impact factor points
Read more about the article Invited talk

Invited talk

  • Post author:Ulf Kahlert
  • Post published:13. January 2024
  • Post category:Allgemein/News

As the world counts down to the 2030 deadline of the UN agenda, major economies like China and Germany are encountering common challenges, which call…

Continue ReadingInvited talk
Read more about the article Local media press release about blood test for detection of pancreatic cancer

Local media press release about blood test for detection of pancreatic cancer

  • Post author:Ulf Kahlert
  • Post published:13. January 2024
  • Post category:Allgemein/News

Our work on early detection of pancreatic cancer in patients blood raised public interest. We continue to thrive for better future care for patients and…

Continue ReadingLocal media press release about blood test for detection of pancreatic cancer
Read more about the article New publication on transcriptional classification of breast cancer susceptibility to immune therapy

New publication on transcriptional classification of breast cancer susceptibility to immune therapy

  • Post author:Ulf Kahlert
  • Post published:9. February 2023
  • Post category:Allgemein

A chromatin regulator-related gene signature was calculated, and this signature provides the strong independent predictive capability for clinical prognosis and immunotherapy efficacy for patients  …

Continue ReadingNew publication on transcriptional classification of breast cancer susceptibility to immune therapy
  • 1
  • 2
  • 3
  • 4
  • Go to the next page

Latest

  • All news are regularly updated on our institutional homepage
  • Science meets business
  • Student evaluation
  • Nomination in scientific society
  • MES New Years Brunch 2024

Impressum | Datenschutz

Cookie Consent Banner by Real Cookie Banner